Light‐ and pH‐Responsive Release of Doxorubicin from a Mesoporous Silica‐Based Nanocarrier
- 17 February 2011
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 17 (12) , 3338-3342
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Doxorubicin: The Good, the Bad and the Ugly EffectCurrent Medicinal Chemistry, 2009
- The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancerCancer Treatment Reviews, 2008
- Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug deliveryChemical Communications, 2008
- Pegylated Liposomal DoxorubicinDrugs, 2008
- Preventive Effect of Erythropoietin on Cardiac Dysfunction in Doxorubicin-Induced CardiomyopathyCirculation, 2006
- State-of-the-Art Therapeutics: Hodgkin's LymphomaJournal of Clinical Oncology, 2005
- Nanoengineered Polymer Capsules: Tools for Detection, Controlled Delivery, and Site‐Specific ManipulationSmall, 2004
- Antitumour activity and adverse reactions of combined treatment with chitosan and doxorubicin in tumour-bearing miceJournal of Pharmacy and Pharmacology, 2001
- Doxorubicin-Induced CardiomyopathyNew England Journal of Medicine, 1998
- Adriamycin (14-hydroxydaunomycin), a novel antitumor antibioticTetrahedron Letters, 1969